Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 886 AL 900

Speech silence character as a diagnostic biomarker of early cognitive decline and its functional mechanism: a multicenter cross-sectional cohort study

Wang HL, Tang R, Ren RJ, Dammer EB, Guo QH, Peng GP, Cui HL, Zhang YM, Wang JT, Xie XY, Huang Q, Li JP, Yan FH, Chen SD, He NY, Wang G.

BMC Med. 2022 Nov 7;20(1):380. doi: 10.1186/s12916-022-02584-x.

Blood-based biomarkers in Alzheimer's disease: a mini-review

Padala SP, Newhouse PA.

Metab Brain Dis. 2023 Jan;38(1):185-193. doi: 10.1007/s11011-022-01114-1. Epub 2022 Nov 7.

Metal-organic frameworks: A promising option for the diagnosis and treatment of Alzheimer's disease

Tajahmadi S, Molavi H, Ahmadijokani F, Shamloo A, Shojaei A, Sharifzadeh M, Rezakazemi M, Fatehizadeh A, Aminabhavi TM, Arjmand M.

J Control Release. 2023 Jan;353:1-29. doi: 10.1016/j.jconrel.2022.11.002. Epub 2022 Nov 21.

Omics-based biomarkers discovery for Alzheimer's disease

Aerqin Q, Wang ZT, Wu KM, He XY, Dong Q, Yu JT.

Cell Mol Life Sci. 2022 Nov 8;79(12):585. doi: 10.1007/s00018-022-04614-6.

Driving assessment in preclinical Alzheimer's disease: progress to date and the path forward

Bayat S, Roe CM.

Alzheimers Res Ther. 2022 Nov 8;14(1):168. doi: 10.1186/s13195-022-01109-1.

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, Stomrud E, Tideman P, Ohlsson T, Jögi J, Johnson K, Sperling R, Dore V, Masters CL, Rowe C, Visser D, van Berckel BNM, van der Flier WM, Baker S, Jagust WJ, Wiste HJ, Petersen RC, Jack CR Jr, Hansson O.

Nat Med. 2022 Nov;28(11):2381-2387. doi: 10.1038/s41591-022-02049-x. Epub 2022 Nov 10.

Overview of the blood biomarkers in Alzheimer's disease: Promises and challenges

Delaby C, Hirtz C, Lehmann S.

Rev Neurol (Paris). 2023 Mar;179(3):161-172. doi: 10.1016/j.neurol.2022.09.003. Epub 2022 Nov 10.

PET molecular imaging for pathophysiological visualization in Alzheimer's disease

Wang J, Jin C, Zhou J, Zhou R, Tian M, Lee HJ, Zhang H.

Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):765-783. doi: 10.1007/s00259-022-05999-z. Epub 2022 Nov 14.

Inflammatory Diseases, Inflammatory Biomarkers, and Alzheimer Disease: An Observational Analysis and Mendelian Randomization

Huang J, Su B, Karhunen V, Gill D, Zuber V, Ahola-Olli A, Palaniswamy S, Auvinen J, Herzig KH, Keinänen-Kiukaanniemi S, Salmi M, Jalkanen S, Lehtimäki T, Salomaa V, Raitakari OT, Matthews PM, Elliott P, Tsilidis KK, Jarvelin MR, Tzoulaki I, Dehghan A.

Neurology. 2023 Feb 7;100(6):e568-e581. doi: 10.1212/WNL.0000000000201489. Epub 2022 Nov 16.

Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk: Study protocol for a pilot randomized controlled trial

Mossavar-Rahmani Y, Shaw PA, Hakun JG, Katz MJ, Wylie-Rosett J, Sliwinski MJ.

Contemp Clin Trials. 2023 Jan;124:107006. doi: 10.1016/j.cct.2022.107006. Epub 2022 Nov 14.

Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential

Olichney J, Xia J, Church KJ, Moebius HJ.

Neural Plast. 2022 Nov 8;2022:2104880. doi: 10.1155/2022/2104880. eCollection 2022.

Blood and Cerebrospinal Fluid Biomarkers in Vascular Dementia and Alzheimer's Disease: A Brief Review

Gorelick PB.

Clin Geriatr Med. 2023 Feb;39(1):67-76. doi: 10.1016/j.cger.2022.08.001. Epub 2022 Oct 18.

Modifiable risk factors of dementia linked to excitation-inhibition imbalance

Hafizi S, Rajji TK.

Ageing Res Rev. 2023 Jan;83:101804. doi: 10.1016/j.arr.2022.101804. Epub 2022 Nov 21.

Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review

Santos F, Cabreira V, Rocha S, Massano J.

J Geriatr Psychiatry Neurol. 2023 Jul;36(4):267-281. doi: 10.1177/08919887221141651. Epub 2022 Nov 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias